Gene · 8029
Papers1,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The urinary proteome infers dysregulation of mitochondrial, lysosomal, and protein reabsorption processes in chronic kidney disease of unknown etiology (CKDu). | Am J Physiol Renal Physiol | 2023 | 36794752 | PubTator, text mining | PubMed |
| The Role of Maternal Vitamin D Deficiency in Offspring Obesity: A Narrative Review. | Nutrients | 2023 | 36771240 | PubTator, text mining | PubMed |
| Cadmium-Induced Proteinuria: Mechanistic Insights from Dose-Effect Analyses. | Int J Mol Sci | 2023 | 36768208 | PubTator, text mining | PubMed |
| Consolidation of metabolomic, proteomic, and GWAS data in connective model of schizophrenia. | Sci Rep | 2023 | 36747015 | PubTator, text mining | PubMed |
| Growth of AgI semiconductors on tailored 3D porous Ti3C2 MXene/graphene oxide aerogel to develop sensitive and selective "signal-on" photoelectrochemical sensor for H2S determination. | Anal Chim Acta | 2023 | 36737133 | PubTator, text mining | PubMed |
| Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment. | J Adv Res | 2023 | 36702249 | PubTator, text mining | PubMed |
| Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 36674979 | PubTator, text mining | PubMed |
| Emerging Perspectives on the Rare Tubulopathy Dent Disease: Is Glomerular Damage a Direct Consequence of ClC-5 Dysfunction? | Int J Mol Sci | 2023 | 36674829 | PubTator, text mining | PubMed |
| Concentrations of total, bioavailable, and free 25OHD in individuals with and without primary hyperparathyroidism and their correlations to DXA and trabecular bone score. | Arch Endocrinol Metab | 2023 | 36651703 | PubTator, text mining | PubMed |
| Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry. | Kidney Int | 2023 | 36638888 | PubTator, text mining | PubMed |
| Characterization of Urate Metabolism and Complications of Patients with Renal Hypouricemia. | Intern Med | 2023 | 36418091 | PubTator, text mining | PubMed |
| Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy. | Blood Adv | 2023 | 36399516 | PubTator, text mining | PubMed |
| Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells. | J Pathol | 2023 | 36373978 | PubTator, text mining | PubMed |
| The compound heterozygous mutations of c.607G>a and c.657delC in the FAH gene are associated with renal damage with hereditary tyrosinemia type 1 (HT1). | Mol Genet Genomic Med | 2023 | 36369907 | PubTator, text mining | PubMed |
| Clinical and genetic characterization of children with cubilin variants. | Pediatr Nephrol | 2023 | 36112210 | PubTator, text mining | PubMed |
| Vitamin D Metabolites: Analytical Challenges and Clinical Relevance. | Calcif Tissue Int | 2023 | 35238975 | PubTator, text mining | PubMed |
| Effect of OSLM features and gamification motivators on motivation in DGBL: pupils' viewpoint. | Smart Learn Environ | 2022 | 40477517 | PubTator, text mining | PubMed |
| Endogenous markers of kidney function and renal drug clearance processes of filtration, secretion, and reabsorption. | Curr Opin Toxicol | 2022 | 36777447 | PubTator, text mining | PubMed |
| Group A Streptococcus Infections: Their Mechanisms, Epidemiology, and Current Scope of Vaccines. | Cureus | 2022 | 36721580 | PubTator, text mining | PubMed |
| Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis. | Front Pharmacol | 2022 | 36712680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8029/papers?page=11